Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionJustInvest LLC
Latest Disclosed Ownership23,835 shares
Latest Disclosed Value $ 1,570,965
JustInvest LLC reports 15.01% increase in ownership of 1CYTK / Cytokinetics, Incorporated

On May 14, 2026 - JustInvest LLC filed a 13F-HR form disclosing ownership of 23,835 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $1,287,090 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 20,725 shares of Cytokinetics, Incorporated. This represents a change in shares of 15.01% during the quarter. The current value of the position is $1,485,397 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CYTOKINETICS COM NEW 23282W605 23,835 3,110 15.01 1,571 19.30 0.0154
2026-02-13 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 20,725 2,641 14.60 1,317 32.53 0.0128
2025-10-31 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 18,084 4,493 33.06 994 121.16 0.0102
2025-07-25 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 13,591 1,509 12.49 449 -7.42 0.0051
2025-05-14 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 12,082 5,096 72.95 486 47.87 0.0072
2025-02-10 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 6,986 305 4.57 329 -6.82 0.0050
2024-11-12 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 6,681 -1,363 -16.94 353 -19.08 0.0057
2024-08-12 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 8,044 -638 -7.35 436 -28.45 0.0083
2024-05-09 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 8,682 3,193 58.17 609 32.75 0.0131
2024-02-08 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 5,489 5,489 458 0.0119
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.